In-Depth Cough And Cold Preparations Market Report: Business Trends, Growth Factors, and Forecast to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Cough And Cold Preparations Market Expected to Be in 2029?
The market for subcutaneous immunoglobulin (SCIG) has witnessed robust expansion in recent times. The market is forecasted to grow from $12.72 billion in 2024 to $14.39 billion in 2025, depicting a compound annual growth rate (CAGR) of 13.1%. Several factors contributing to the growth during the historic period include a higher occurrence of immunodeficiency disorders, a surge in patient preference for home-based treatments, improved therapeutic efficacy, an increase in awareness and diagnosis rates, as well as the development of favourable reimbursement policies.
In the forthcoming years, the subcutaneous immunoglobulin (SCIG) market is projected to experience significant expansion. It is forecasted to reach “$23.23 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.7%. The anticipated growth during the projection period can be linked to the increasing incidence of neurological disorders, the surge in autoimmune diseases, growing consciousness and acceptance of immunoglobulin therapy, widening applications in neurological and dermatological fields, and the growth of healthcare facilities. Looking into the forecast period, key trends include the evolution in drug delivery systems, a growing demand for home infusion therapies, advancements in antibody therapy, innovations in medication formulations, and advancements in SCIG.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp
What Are The Contributors To Demand In The Cough And Cold Preparations Market?
The escalation in allergy occurrences is predicted to spur the expansion of the cough and cold preparations market during the projected period. Various respiratory allergies, including pollen, dust, mold, and pet allergies, are triggered by polluted indoor and outdoor air. Cough and cold remedies are commonly taken to tackle allergies that result in coughs and respiratory tract problems. For example, data from the European Academy of Allergy and Clinical Immunology – a non-profit entity for European clinicians, researchers, and healthcare professionals, suggests that by 2025, allergies will impact one in every three people in the European Union. Consequently, the rise in respiratory allergy cases will strengthen the need for cough and cold preparations, thereby influencing the market’s growth positively.
The subcutaneous immunoglobulin (scig) market covered in this report is segmented –
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM
What Notable Trends Are Shaping The Direction Of The Cough And Cold Preparations Market?
Prominent entities in the subcutaneous immunoglobulin market are working on the production of subcutaneous human-klhw, a distinct blend with human immune globulins (Ig) that boosts the body’s immunity. This formulation of subcutaneous human-klhw is designed for subcutaneous use and specifically focused on managing primary immunodeficiencies in human bodies. For example, in March 2022, Grifols S.A., a pharmaceutical firm based in Spain, introduced XEMBIFY 20% subcutaneous immunoglobulin (SCIG), exclusively engineered to address primary immunodeficiency, which caters to a significant healthcare requirement for individuals with compromised immune systems. XEMBIFY is a ready-to-use product that streamlines the treatment procedure and augments patient comfort. With a shelf-life of 24 months at ambient room temperature, this eliminates the requirement for refrigeration during storage and transport, making it very practical in various healthcare environments.
Who Are The Top-Ranked Companies In The Cough And Cold Preparations Market Today?
Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy’s Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc
How Is Cough And Cold Preparations Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the subcutaneous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15935&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
